Join Dr. Brahmer at the 20th Annual Winter Lung Cancer Conference

(1:31)

Dr. Julie Brahmer Invites you to the 18th Annual Winter Lung Cancer Conference®

(41)

Dr. Brahmer on Managing Immune-Related AEs in Lung Cancer

(1:29)

Dr. Brahmer on Distinguishing Between Immunotherapy Response and Cancer Growth

(1:16)

Dr. Julie R. Brahmer Invites You to The 19th Annual Winter Lung Cancer Conference®

(49)

KMTV Omaha - Interview with Omaha native, Dr. Julie Brahmer

(4:16)

What is Dr. Julie R. Brahmer looking forward to at the 18th Annual Winter Lung Cancer Conference®?

(33)

An Answer to Cancer? Using the immune system to fight cancer -- Longwood Seminar

(1:32:16)

Immunotherapy for Lung Cancer: What Patients Need to Know, with Julie Brahmer

(1:52)

Managing Immunotherapy Side Effects

(12:39)

Discovering the PD-1 Checkpoint: Winners of the 2014 William B. Coley Award for Tumor Immunology

(3:40)

Cancer genes

(30:33)

April 9, 2024 - Beshay Zordosky, MSc, PhD

(59:9)

Immunotherapy Updates Unlocked: An Interactive Digital Engagement Showcase

(31:25)

Gaining an Advantage Over NSCLC: How to Achieve the Greatest Benefit With Immunotherapy

(1:44:45)

Doctors Discuss: Immunotherapy in Lung Cancer

(26:2)

How is Immunotherapy Used to Fight Cancer? | Dana-Farber Cancer Institute | Science Illustrated

(2:44)

Dr. Julie R. Brahmer on the \

(24)

Dr. Brahmer Discusses the Management of Adverse Events From Immunotherapy

(1:30)

Dr. Brahmer on the Role of Immunotherapy in Metastatic NSCLC

(1:31)

Dr. Brahmer on the Benefit of Immunotherapy in Metastatic NSCLC

(1:32)

Dr Brahmer on the Investigation of FLX475 in NSCLC

(2:19)

Dr. Brahmer Discusses Response to Immunotherapy

(1:25)

Dr. Brahmer on Impact of CheckMate-057 in NSCLC

(1:54)

Dr. Brahmer Discusses the Outlook for Immunotherapies

(58)

Dr. Brahmer on 5-Year Follow-Up Data for Nivolumab in NSCLC

(1:18)

Dr. Brahmer on Chemoimmunotherapy in Patients With NSCLC

(1:25)

Dr. Brahmer on the Role of PD-1 and PD-L1

(1:53)

Dr Julie Brahmer : Lung Cancer Immunotherapy

(31:51)